UnicomIG
0.1.0 - ci-build

UnicomIG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/unicom-ig/ and changes regularly. See the Directory of published versions

Example Bundle: 004-Cefuroxime-MIP-1500mg-EE-FullProduct

Cefuroxime MIP 1500 mg, süste-/infusioonilahuse pulber

MPID: EE-100009199-27834
PMSID: EE0000002

Full name: Cefuroxime MIP 1500 mg, süste-/infusioonilahuse pulber

- Invented name part: Cefuroxime MIP

- Strength part: 1500 MG

Name usage: Estonian (Republic of Estonia)

Authorised dose form: Powder for solution for injection/infusion

Legal status of supply: Medicinal Product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000096183 Cefuroxime
  • J01DC02 cefuroxime

Marketing Authorisation 1 of 1

Authorisation number: 805813

Region: Republic of Estonia

Marketing authorisation holder: Mip Pharma GmbH

Identifier:

  • LOC-100009199

Status: Valid - Renewed/Varied (2017-12-06)

Package 1 of 2

PCID: EE-100009199-27834-1529940

Description:
I tüüpi klaasist viaal, mis on suletud klorobutüülkummist korgi ning flip-off kattega, 1 viaal

Marketing status:

  • Republic of Estonia: Marketed

Pack size:

  • 1 vial

Package: 1 Box (Cardboard)

Containing:

Package: 1 vial (Glass type I)

Containing: 1

Manufactured Item

Dose form: Powder for solution for injection/infusion

Unit of presentation: Vial

Ingredient

Role: Active

Substance: CEFUROXIME SODIUM

Presentation strength: 1578 milligram(s) / 1 Vial

Reference strength:
CEFUROXIME 1500 milligram(s) / 1 Vial

Package 2 of 2

PCID: EE-100009199-27834-1529962

Description:
I tüüpi klaasist viaal, mis on suletud klorobutüülkummist korgi ning flip-off kattega, 10 viaali

Marketing status:

  • Republic of Estonia: Marketed

Pack size:

  • 10 Vial

Package: 1 Box (Cardboard)

Containing:

Package: 10 vial (Glass type I)

Containing: 1

Manufactured Item

Dose form: Powder for solution for injection/infusion

Unit of presentation: Vial

Ingredient

Role: Active

Substance: CEFUROXIME SODIUM

Presentation strength: 1578 milligram(s) / 1 Vial

Reference strength:
CEFUROXIME 1500 milligram(s) / 1 Vial

Administrable Product (1 of 1)

Dose form: Solution for injection/infusion

Unit of presentation: Vial

Route of administration:

  • Intramuscular use

Ingredients:

Ingredient

Role: Active

Substance: CEFUROXIME SODIUM

Presentation strength: 1578 milligram(s) / 1 Vial

Reference strength:
CEFUROXIME 1500 milligram(s) / 1 Vial